A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients ...

While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

Cancer doctors, scientists, and patient advocates said the “cancer” label can do more harm than good, given this form of the ...

THE International Teacher Training Academy (ITTA) team in Coffs Harbour has completed its month-long participation in the ...

Research shows 69 per cent of Black adults are unaware that Black men face a two-fold increased risk of developing prostate ...

Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

Researchers from universities including Harvard and the University of California met with participants from multiple fields, ...

The Krabby Patty is coming to Wendy's restaurants nationwide for a limited time. Yes, really. Florida’s Retirees Are Fleeing: ...

Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...

More than a third of men over the age of 40 have a prostate cancer screening with a PSA test. Still, experts agree it’s unclear if the benefits of the cancer screenings using PSA tests outweigh the ...

Adding external beam radiotherapy did not improve biochemical failure outcomes or prostate cancer specific mortality in ...

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation ...